BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 32559341)

  • 21. Clinical impact of molecular and cytogenetic findings in synovial sarcoma.
    Panagopoulos I; Mertens F; Isaksson M; Limon J; Gustafson P; Skytting B; Akerman M; Sciot R; Dal Cin P; Samson I; Iliszko M; Ryoe J; Dêbiec-Rychter M; Szadowska A; Brosjö O; Larsson O; Rydholm A; Mandahl N
    Genes Chromosomes Cancer; 2001 Aug; 31(4):362-72. PubMed ID: 11433527
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Frequent TRPS1 expression in synovial sarcoma is associated with SS18-SSX fusion oncoprotein activity.
    Cloutier JM; Ingram DR; Wani K; Lazar AJ; Wang WL
    Hum Pathol; 2022 Dec; 130():88-94. PubMed ID: 36162599
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synovial Sarcoma of the Gastrointestinal Tract.
    Ortiz Requena D; Longacre TA; Rosenberg AE; Velez Torres JM; Yanchenko N; Garcia-Buitrago MT; Voltaggio L; Montgomery EA
    Mod Pathol; 2024 Jan; 37(1):100383. PubMed ID: 37972927
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel fluorescence in situ hybridization assay for synovial sarcoma.
    Kato K; Tanaka M; Toyoda Y; Kigasawa H; Ohama Y; Nishi T; Okuzumi S; Kurosawa K; Aida N; Nagahara N; Tanaka Y
    Pathol Res Pract; 2013 May; 209(5):309-13. PubMed ID: 23623359
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Primary synovial sarcoma of bone: a retrospective analysis of 25 patients.
    Righi A; Gambarotti M; Benini S; Gibertoni D; Asioli S; Magagnoli G; Gamberi G; Sbaraglia M; Cocchi S; Staals E; Palmerini E; Dei Tos AP
    Histopathology; 2022 Mar; 80(4):686-697. PubMed ID: 34821406
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Analysis of SYT/SSX1 and SYT/SSX2 fusion genes from synovial sarcoma].
    Kekeeva TV; Riazantseva AA; Zavalishina LÉ; Andreeva IuIu; Babenko OV; Zaletaev DV; Frank GA
    Mol Biol (Mosk); 2011; 45(5):840-4. PubMed ID: 22393780
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The clinical implication of SS18-SSX fusion gene in synovial sarcoma.
    Ren T; Lu Q; Guo W; Lou Z; Peng X; Jiao G; Sun Y
    Br J Cancer; 2013 Oct; 109(8):2279-85. PubMed ID: 24022186
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synovial sarcoma showing loss of a green signal in SS18 fluorescence in situ hybridization: a clinicopathological and molecular study of 12 cases.
    Jiang D; Peng R; Yan X; Chen M; Lan T; Chen H; Zhang Z; Jing W; Jiang L; Ma L; Zhang H
    Virchows Arch; 2017 Dec; 471(6):799-807. PubMed ID: 28761985
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SS18-SSX Antibody: A Useful Tool to Save Time and Reduce Costs in Synovial Sarcoma Diagnosis. Proposal of a Novel Diagnostic Algorithm.
    Orlando G; Santoro F; Linari A; Tampieri C; Verdun di Cantogno L; De Meo S; Ratto N; Grignani G; Papotti M; Senetta R
    J Histochem Cytochem; 2023 Jul; 71(7):377-385. PubMed ID: 37357741
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SS18-SSX Expression in a Contemporary Cohort of Primary Renal Synovial Sarcoma: A Multi-Institutional Experience of Fourteen Patients.
    Challa B; Mohanty SK; Jha S; Sampat NY; Sardana R; Lobo A; Sharma S; Arora S; Rath D; Munjal G; Pattnaik N; Jain D; Jain E; Dewan A; Dixit M; Malik V; Shinde S; Balzer BL; Parwani A
    Int J Surg Pathol; 2023 Oct; 31(7):1232-1243. PubMed ID: 36591871
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Diagnostic value of SYT-SSX fusion gene detection by fluorescence in-situ hybridization for synovial sarcoma].
    Sun Y; Sun BC; Liu YX; Zhang SW; Zhao XL; Wang J; Hao XS
    Zhonghua Bing Li Xue Za Zhi; 2008 Oct; 37(10):660-4. PubMed ID: 19094483
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SYT-SSX gene fusion as a determinant of morphology and prognosis in synovial sarcoma.
    Kawai A; Woodruff J; Healey JH; Brennan MF; Antonescu CR; Ladanyi M
    N Engl J Med; 1998 Jan; 338(3):153-60. PubMed ID: 9428816
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunoreactivity of a Monoclonal Antibody to SS18-SSX Fusion Gene Product in Formalin-fixed Paraffin-embedded Synovial Sarcoma Tissue Section.
    Saigo C; Kito Y; Takeuchi T
    Appl Immunohistochem Mol Morphol; 2018 Mar; 26(3):206-211. PubMed ID: 27362474
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Detection of SYT-SSX fusion gene in paraffin-embedded tissues and its clinicopathologic significance for synovial sarcoma].
    Wei Y; Sun M; Zhu H; Xu Z; Wang J; Zhu X
    Zhonghua Bing Li Xue Za Zhi; 2001 Dec; 30(6):426-30. PubMed ID: 11866984
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Strong association of SYT-SSX fusion type and morphologic epithelial differentiation in synovial sarcoma.
    Antonescu CR; Kawai A; Leung DH; Lonardo F; Woodruff JM; Healey JH; Ladanyi M
    Diagn Mol Pathol; 2000 Mar; 9(1):1-8. PubMed ID: 10718206
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison between Fluorescence in-situ Hybridization (FISH), Reverse Transcriptase PCR (RT-PCR) and fragment analysis, for detection of t (X; 18) (p11; q11) translocation in synovial sarcomas.
    Shetty O; Pai T; Gurav M; Rekhi B
    Indian J Pathol Microbiol; 2020; 63(1):64-72. PubMed ID: 32031125
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SS18-SSX fusion protein-induced Wnt/β-catenin signaling is a therapeutic target in synovial sarcoma.
    Trautmann M; Sievers E; Aretz S; Kindler D; Michels S; Friedrichs N; Renner M; Kirfel J; Steiner S; Huss S; Koch A; Penzel R; Larsson O; Kawai A; Tanaka S; Sonobe H; Waha A; Schirmacher P; Mechtersheimer G; Wardelmann E; Büttner R; Hartmann W
    Oncogene; 2014 Oct; 33(42):5006-16. PubMed ID: 24166495
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Loss of SS18-SSX1 inhibits viability and induces apoptosis in synovial sarcoma.
    Carmody Soni EE; Schlottman S; Erkizan HV; Uren A; Toretsky JA
    Clin Orthop Relat Res; 2014 Mar; 472(3):874-82. PubMed ID: 23716114
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of SYT-SSX fusion type on the clinical behavior of synovial sarcoma: a multi-institutional retrospective study of 243 patients.
    Ladanyi M; Antonescu CR; Leung DH; Woodruff JM; Kawai A; Healey JH; Brennan MF; Bridge JA; Neff JR; Barr FG; Goldsmith JD; Brooks JS; Goldblum JR; Ali SZ; Shipley J; Cooper CS; Fisher C; Skytting B; Larsson O
    Cancer Res; 2002 Jan; 62(1):135-40. PubMed ID: 11782370
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of TLE1, INI1, β-catenin, Claudin1, CK7, CK19, SS18 and calponin in synovial sarcoma.
    Madakshira MG; Radotra BD; Kaman L; Saikia UN
    Indian J Pathol Microbiol; 2021; 64(4):707-716. PubMed ID: 34673590
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.